Merck (MRK) Total Non-Current Liabilities (2009 - 2026)

Merck (MRK) has reported Total Non-Current Liabilities for 17 consecutive years, with $16.2 billion the latest figure, recorded in Q2 2026.

• On a quarterly basis, Total Non-Current Liabilities fell 73.69% year-over-year to $16.2 billion in Q2 2026; TTM through Jun 2026 was $16.2 billion, a 73.69% decrease from a year earlier, with the FY2025 full-year figure at $13.6 billion, changed N/A from the prior year.
• Total Non-Current Liabilities was $16.2 billion for Q2 2026 at Merck, down from $75.1 billion in the prior quarter.
• Over five years, Total Non-Current Liabilities peaked at $75.1 billion in Q1 2026 and troughed at $600.0 million in Q1 2022.
• A 5-year average of $14.2 billion and a median of $750.0 million in 2023 frame the typical range for Total Non-Current Liabilities.
• Across the five-year window, Total Non-Current Liabilities soared 8090.93% in 2025 and sank 73.69% in 2026, its largest moves.
• Over 5 years, Total Non-Current Liabilities stood at $600.0 million in 2022, then gained by 25.0% to $750.0 million in 2023, then changed by 0.0% to $750.0 million in 2024, then soared by 1709.73% to $13.6 billion in 2025, then grew by 19.09% to $16.2 billion in 2026.
• The last three Total Non-Current Liabilities figures came in at $16.2 billion (Q2 2026), $75.1 billion (Q1 2026), and $13.6 billion (Q4 2025), per Business Quant data.